Helgerud P, Petersen L B, Norum K R
J Clin Invest. 1983 Mar;71(3):747-53. doi: 10.1172/jci110822.
The mechanism of the intestinal esterification of retinol has been obscure. Recently, an acyl-Coenzyme A (CoA):retinol acyltransferase (ARAT) was found in rat intestinal microsomes, and experiments were therefore conducted to determine whether a corresponding enzyme exists in human small intestine. When microsomes were incubated with [3H]retinol and palmitoyl-CoA, or retinol and [1-14C]palmitoyl-CoA, radioactive retinyl palmitate was formed as identified by alumina column chromatography and reverse-phase high-pressure liquid chromatography. Heating the microsomes for 30 min at 60 degrees C resulted in loss of activity. The esterification was negligible without exogenous acyl-CoA and markedly stimulated by palmitoyl-, oleoyl-, and stearoyl-CoA in concentrations up to 20 microM. The acyl-CoA was successfully replaced by an acyl-CoA generating system, but not by unactivated palmitate (2.5-200 microM). The assay was dependent on the presence of albumin with optimum activity at 2-10 mg/ml. The optimal retinol concentration was 20-30 microM and pH approximately 7.4. The esterifying activity was completely inhibited by 8 mM of taurocholate and to 90% by 1 mM of 5,5'-dithiobis(2-nitrobenzoic acid). Activity was found throughout the small intestine. In jejunum the rate of retinol esterification was: 3.44 +/- 2.24 nmol [3H]retinyl ester formed . mg microsomal protein-1 . min-1 (mean +/- SD, n = 12). The corresponding activity in whole homogenates of biopsies were 1.17 +/- 0.28 (n = 8). It is concluded that human small intestine contains a microsomal acyl-CoA:retinol acyltransferase. Due to its high activity in vitro this enzyme is likely to be responsible for the intestinal esterification of retinol.
视黄醇在肠道中酯化的机制一直不明。最近,在大鼠肠道微粒体中发现了一种酰基辅酶A(CoA):视黄醇酰基转移酶(ARAT),因此开展了实验以确定人类小肠中是否存在相应的酶。当微粒体与[3H]视黄醇和棕榈酰辅酶A,或视黄醇与[1-14C]棕榈酰辅酶A一起温育时,通过氧化铝柱色谱法和反相高压液相色谱法鉴定发现形成了放射性视黄醇棕榈酸酯。将微粒体在60℃加热30分钟会导致活性丧失。在没有外源性酰基辅酶A的情况下,酯化作用可忽略不计,而棕榈酰辅酶A、油酰辅酶A和硬脂酰辅酶A在浓度高达20μM时可显著刺激酯化作用。酰基辅酶A成功地被一个酰基辅酶A生成系统所替代,但未被未活化的棕榈酸(2.5 - 200μM)替代。该测定依赖于白蛋白的存在,在2 - 10mg/ml时活性最佳。最佳视黄醇浓度为20 - 30μM,pH约为7.4。8mM的牛磺胆酸盐可完全抑制酯化活性,1mM的5,5'-二硫代双(2-硝基苯甲酸)可将其抑制90%。在整个小肠中均发现有活性。在空肠中,视黄醇酯化速率为:3.44±2.24 nmol [3H]视黄醇酯形成·mg微粒体蛋白-1·min-1(平均值±标准差,n = 12)。活检全匀浆中的相应活性为1.17±0.28(n = 8)。结论是人类小肠含有一种微粒体酰基辅酶A:视黄醇酰基转移酶。由于其在体外具有高活性,该酶可能负责视黄醇在肠道中的酯化作用。